Glibenclamide-pregnenolone derivative has greater hypoglycemic effects and biodistribution than glibenclamide-OH in alloxan-rats
Language English Country Czech Republic Media print
Document type Journal Article
PubMed
22660215
DOI
10.5507/bp.2012.028
Knihovny.cz E-resources
- MeSH
- Alloxan MeSH
- Diabetes Mellitus, Experimental blood MeSH
- Drug Combinations MeSH
- Glyburide analogs & derivatives pharmacokinetics therapeutic use MeSH
- Hypoglycemic Agents metabolism pharmacokinetics MeSH
- Blood Glucose metabolism MeSH
- Rats MeSH
- Metformin therapeutic use MeSH
- Rats, Wistar MeSH
- Pregnenolone pharmacokinetics therapeutic use MeSH
- Tissue Distribution MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Alloxan MeSH
- Drug Combinations MeSH
- Glyburide MeSH
- Hypoglycemic Agents MeSH
- Blood Glucose MeSH
- Metformin MeSH
- Pregnenolone MeSH
AIM: The present study was designed to investigate the activity of two glibenclamide derivatives on glucose concentration. An additional aim was to identify the biodistribution of glibenclamide derivatives in different organs in a diabetic animal model. METHODS: The effects of two glibenclamide derivatives on glucose concentration were evaluated in a diabetic animal model. In addition, glibenclamide derivatives were bound to Tc-99m using radioimmunoassay methods. To evaluate the pharmacokinetics of the glibenclamide derivatives over time (15, 30, 45 and 60 min) the Tc-99m-glibenclamide conjugates were used. RESULTS: The results showed that glibenclamide-pregnenolone had greater hypoglycemic activity than glibenclamide or glibenclamide-OH. The data also showed that the biodistribution of Tc-99m-glibenclamide-OH in all organs was less than that of the Tc-99m-glibenclamide-pregnenolone derivative. CONCLUSIONS: The glibenclamide-pregnenolone derivative had greater hypoglycemic effects and its biodistribution was wider than glibenclamide-OH. The data suggest that the steroid nucleus may be important to the hypoglycemic activity of the glibenclamide-pregnenolone derivative and this could be related to the degree of lipophilicity induced by the steroid nucleus in the chemical structure of glibenclamide-pregnenolone.
References provided by Crossref.org